Lv4
790 积分 2022-05-09 加入
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
2个月前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
2个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
2个月前
已完结
Prevalence and Trend of Biopsy-Proven IgA Nephropathy in China: A Systematic Review
2个月前
已完结
Targeting the Pathogenesis of IgA Nephropathy — A New Treatment Approach?
2个月前
已完结
The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer
3个月前
已完结
Establishment of Membrane-Bound IgA1-Specific Antibody Possessing Antibody-Dependent Cellular Cytotoxicity Activity
3个月前
已完结
Antigens in membranous nephropathy: discovery and clinical implications
4个月前
已完结
Glycosylation Modulates Human CD2-CD58 Adhesion via Conformational Adjustment
6个月前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
7个月前
已完结
皖公网安备34019202002308
